Home/Investigations/EllieMD
Tracked public case
EllieMD LLC
TrackedCash-pay telehealth marketing compounded GLP-1s and peptides, with a Brand Partner / MLM layer — and research-grade peptides offered for human consumption.
Overview
EllieMD is a direct-to-consumer telehealth brand that markets compounded weight-loss and wellness peptides through an online consultation and fulfillment model. Public marketing and consumer reports also describe a Brand Partner (network / MLM-style) recruitment layer layered on top of patient product sales.
This desk tracks three interconnected themes that appear across public surfaces: (1) compounded GLP-1 and related peptide offers sold as clinical telehealth products; (2) Brand Partner compensation, recruitment, and earnings framing that consumers and aspiring affiliates see in public programs; and (3) research-grade peptides offered for human consumption — sold or positioned as if they were pharmacy / prescription-grade medicine.
We do not assert courtroom conclusions here. We document public marketing, packaging and review patterns, and complaint themes so regulators, newsrooms, and nonprofit partners can evaluate the record for themselves. Complaint intake remains open for EllieMD and any other telehealth company.
Why we track it. High-visibility cash-pay GLP-1 / peptide telehealth with an MLM-style affiliate layer and research-grade product questions that keep recurring in public consumer materials.
Tracked public case. Pattern and packaging context for partners; complaint form accepts EllieMD and other companies; curated partner briefs available on request.
Public record timeline
- Ongoing
Public marketing of compounded GLP-1 and peptide SKUs via telehealth intake
- Ongoing
Brand Partner / affiliate program materials visible on enrollment and partner surfaces
- Ongoing
Consumer forums and reviews discussing fulfillment, product representation, and affiliate pressure
Focus areas
- Compounded GLP-1 and related peptide marketing claims
- Brand Partner / affiliate MLM compensation and recruitment opacity
- Research-grade peptides offered for human consumption (sold as prescription-grade)
- §503A / bulk-substance eligibility questions on marketed peptide SKUs
- Consumer billing, fulfillment, and refund themes in public reviews
Key coverage & sources
- Company marketing site
- Consumer review platforms
- Public Brand Partner materials
Issue tracks
- INF-001
Branded trial data on compounded products
- INF-002
Oral GLP-1 / GIP drops claims
- INF-008
MLM Brand Partners / compensation opacity
- INF-010
Research-grade peptides offered for human consumption
Consumer reports
Complaint form accepts this company and others. Themes seen in public consumer reports include Brand Partner fees, compounded GLP-1 experiences, and research-grade peptides offered for human consumption.
Submit a complaint →Partner findings
Journalists and advocacy groups can request access to curated findings briefs.
Investigative partners →